The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
November 26th 2024
Once relatively obscure, PBMs are now front and center in debates over drug pricing and access. Their future role will have profound implications not only for how medications are priced but also for how pharmacies conduct their operations.
Pharmacy Students Explore Podcasting to Educate, Entertain
April 5th 2021With their content ranging from pharmacy references in pop culture to more clinical discussions of specific drugs, the Let's Pharmonize podcast hosts have learned to balance the rigors of school with their biweekly podcast.
Watch
Consider Pharmacokinetics, Proper Measurements When Treating Children with Obesity
April 5th 2021In addition to the usual considerations of treating pediatric patients, clinicians should consider how pharmacokinetics may differ for children with obesity, according to a session at the 2021 virtual National Association of Pediatric Nurse Practitioners meeting.
Read More
COVID-19 Has Devastating Effects for Patients Suffering From COPD
While the prevalence of COVID-19 in patients with COPD is relatively low, those who are infected with the virus experience more severe symptoms than those without COPD.
Read More
Flu Vaccination Associated With Fewer COVID-19 Cases, Less Severe Symptoms
April 2nd 2021Patients who received a flu shot during the last flu season were significantly less likely to test positive for a COVID-19 infection at the start of the pandemic, according to a study published in the American Journal of Infection Control.
Read More
Pharmacy Fact: Bloodletting Found Not as Successful as Previously Thought
April 2nd 2021Although bloodletting had been praised by medical professionals for more than 2 millennia, not all patients were as enthused at being purged of their blood as their physicians were, regardless of the claims of its efficacy.
Read More
Study: Drug Coupons, Vouchers Cover Minimum of Prescription Drugs
April 1st 2021The researchers analyzed millions of pharmacy transactions by more than 600,000 people in the United States from 2017 to 2019 in order to get a better sense of how vouchers and other point-of-sale co-payment offsets are used.
Read More
How Pharmacists Can Support Health Care Access and Engagement for Black Same-gender-loving Men
April 1st 2021Russell Brewer, DrPH, a research associate professor at University of Chicago Medicine, discusses the value of the pharmacist in improving access and engagement in care for Black same-gender-loving men.
Watch
APhA Releases New Guide on Trans Inclusion for Pharmacies on Trans Day of Visibility
March 31st 2021March 31 is International Transgender Day of Visibility, and the Human Rights Campaign (HRC) Foundation and the American Pharmacists Association (APhA) partnered to release a new guide for pharmacies on transgender and gender-diverse inclusion.
Read More
NAPNAP Recommends Continued Health Provider Efforts to Eliminate Teen E-Cigarette Use
March 31st 2021Despite significant decreases in 2020, a large number of adolescents less than 18 years of age continue to use e-cigarettes, with considerable adverse health effects, according to a presentation at the 2021 National Association of Pediatric Nurse Practitioners (NAPNAP) conference.
Read More
Study: Face Masks Strongly Associated With Reducing Health Care Workers' Risk of Acquiring COVID-19
March 31st 2021The team discovered a correlation between the implementation of Henry Ford’s universal mask policy and a significant drop in the rate at which its health care workers tested positive for SARS-CoV-2.
Read More
Study: Vitamin D Supplementation Could Protect From Severe COVID-19
March 31st 2021Earlier research has found that vitamin D supplementation can prevent inflammation in other respiratory diseases, but there have been limited studies examining the role of vitamin D supplementation in COVID-19.
Read More
Pfizer-BioNTech COVID-19 Vaccine Shows Positive Topline Results in Adolescents
March 31st 2021The results from a phase 3 trial in a population of American adolescents aged 12 to 15 years found that the Pfizer-BioNTech COVID-19 vaccine BNT162b2 showed 100% efficacy and robust antibody responses.
Read More